Enlivex Therapeutics Ltd. is a biotechnology company focused on developing and commercializing transformative cell-based immunotherapies for the treatment of a range of diseases. With a strong pipeline and innovative approach, Enlivex is poised to make a significant impact on the field of immunotherapy.
